BE866660A - Procede de preparation de n-alkyl-n-acyl-thienamycines et leur utilisation - Google Patents

Procede de preparation de n-alkyl-n-acyl-thienamycines et leur utilisation

Info

Publication number
BE866660A
BE866660A BE187350A BE187350A BE866660A BE 866660 A BE866660 A BE 866660A BE 187350 A BE187350 A BE 187350A BE 187350 A BE187350 A BE 187350A BE 866660 A BE866660 A BE 866660A
Authority
BE
Belgium
Prior art keywords
thienamycines
acyl
alkyl
preparation
Prior art date
Application number
BE187350A
Other languages
English (en)
French (fr)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of BE866660A publication Critical patent/BE866660A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65611Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. penicillins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE187350A 1977-05-05 1978-05-03 Procede de preparation de n-alkyl-n-acyl-thienamycines et leur utilisation BE866660A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/793,974 US4235917A (en) 1977-05-05 1977-05-05 N-Alkyl-N-acyl derivatives of thienamycin

Publications (1)

Publication Number Publication Date
BE866660A true BE866660A (fr) 1978-11-03

Family

ID=25161301

Family Applications (1)

Application Number Title Priority Date Filing Date
BE187350A BE866660A (fr) 1977-05-05 1978-05-03 Procede de preparation de n-alkyl-n-acyl-thienamycines et leur utilisation

Country Status (14)

Country Link
US (1) US4235917A (hr)
JP (1) JPS53137992A (hr)
BE (1) BE866660A (hr)
CH (1) CH638209A5 (hr)
DE (1) DE2819479A1 (hr)
DK (1) DK170678A (hr)
ES (1) ES469425A1 (hr)
FR (1) FR2389629B1 (hr)
GB (1) GB1604276A (hr)
IE (1) IE46877B1 (hr)
IT (1) IT1105291B (hr)
LU (1) LU79597A1 (hr)
NL (1) NL7804230A (hr)
SE (1) SE7804446L (hr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839352A (en) * 1975-11-21 1989-06-13 Merck & Co., Inc. N-acyl derivatives of thienamycin
US4318912A (en) * 1979-01-02 1982-03-09 Merck & Co., Inc. 6-(1-Hydroxyethyl)-3-substituted-1-azabicyclo(3.2.0)-hept-2-en-7-one-2-carboxylic acid
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
EP0024832B1 (en) * 1979-08-10 1985-03-13 Beecham Group Plc Beta-lactam antibiotics, their preparation, pharmaceutical compositions containing them and their preparation
US4361512A (en) * 1980-11-26 1982-11-30 Merck & Co., Inc. 2-Substituted thio-6-substituted-carbapen-2-em-3-carboxylic acids
JPS5857392A (ja) * 1981-10-02 1983-04-05 Sanraku Inc 新規な抗生物質oa−6129のリン酸エステル
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4552696A (en) * 1982-04-09 1985-11-12 Bristol-Myers Company Carbapenem antibiotics
ZA832412B (en) * 1982-04-09 1983-12-28 Bristol Myers Co Carbapenem antibiotics
US4529597A (en) * 1982-04-19 1985-07-16 Merck & Co., Inc. Substituted 1-azabicyclo(3.2.0)hept-6-en-2-one-7-carboxylic acids
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
ZA834472B (en) * 1982-06-18 1984-03-28 Bristol Myers Co Carbepenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
ZA841643B (en) * 1983-03-08 1984-10-31 Bristol Myers Co Carbapenem process
US4992542A (en) * 1984-01-24 1991-02-12 Merck & Co., Inc. 2-substituted-6-carbadethiapen-2-em-3-carboxylic acids
US5496816A (en) * 1994-03-14 1996-03-05 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
CH632508A5 (de) * 1975-11-21 1982-10-15 Merck & Co Inc Verfahren zur herstellung von neuen estern des n-acylierten thienamycins.
US4150145A (en) * 1977-09-15 1979-04-17 Merck & Co., Inc. N-alkylated derivatives of thienamycin sulfoxide and sulfone

Also Published As

Publication number Publication date
GB1604276A (en) 1981-12-09
IE780899L (en) 1978-11-05
JPS53137992A (en) 1978-12-01
ES469425A1 (es) 1980-01-01
NL7804230A (nl) 1978-11-07
LU79597A1 (fr) 1979-02-02
DE2819479C2 (hr) 1992-04-30
FR2389629A1 (hr) 1978-12-01
US4235917A (en) 1980-11-25
IT7849175A0 (it) 1978-05-03
JPH0222076B2 (hr) 1990-05-17
IE46877B1 (en) 1983-10-19
FR2389629B1 (hr) 1980-06-20
SE7804446L (sv) 1978-11-06
IT1105291B (it) 1985-10-28
CH638209A5 (de) 1983-09-15
DK170678A (da) 1979-01-16
DE2819479A1 (de) 1978-11-16

Similar Documents

Publication Publication Date Title
FR2449699B1 (fr) Polyetherpolyamides et leur procede de preparation
LU79597A1 (fr) Procede de preparation de n-alkyl-n-acyl-thienamycines et leur utilisation
BE863872A (fr) Steroides-11 beta-substitues et procede de leur preparation
BE866841A (fr) Procede de preparation d'imidazoazines et -diazines substituees et leur utilisation
BE869163A (fr) Thioethers basiques et leur procede de preparation
BE873136A (fr) Procede de preparation de la vincadifformine
BE869074A (fr) Diurethannes, leur procede de preparation et leur utilisation
BE864739A (fr) Polypeptides et procede pour leur preparation
BE865136A (fr) Composes de 2-phenoxy-5-trifluoromethylpyridine et leur procede de preparation
SE7809040L (sv) Apparat for indrivning av festorgan
BE865805A (fr) 1,2,3-thiadiazol-3-in-5-ylidene-urees, leur procede de preparation et leur utilisation
BE856220A (fr) Polyether-polyureides et procede de leur preparation
BE884286A (fr) Acylurees, leur procede de preparation et leur utilisation
BE883348A (fr) Thiazolylidene-oxo-propionitriles, leur procede de preparation et leur utilisation
BE872294A (fr) Procede de preparation de 3-iodorifamycine s et de 3-bromorifamycine s
BE884652R (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
BE862800A (fr) Nouvelles dithienylalkylamines et procede pour leur preparation
BE871647A (fr) Colorants, leur procede de preparation et leur utilisation
LU79551A1 (fr) Procede de preparation de nouvelles 3-amino-2-or-propoxy-naphtyridines et leur utilisation
FR2299865A1 (fr) Arylmethyl-1 imidazolidones-2 et leur procede de preparation
BE868027A (fr) Nouvelles pyridazinylhydrazones et leur procede de preparation
BE869407A (fr) 2-cyclopropyl-chromones substituees et procede pour leur preparation
FR2424281B1 (fr) Phenoxyalcoyl trialcoxysilanes et leur procede de preparation
BE865151A (fr) 1 alpha, 2 alpha-methylenesteroides hydroxyles, leur procede de preparation et leur utilisation
BE870104A (fr) Procede de preparation de 2-chlorosulfinyl-azetidin-4-ones

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MERCK & CO. INC.

Effective date: 19840503